Sort
64,565 grants matching “drug discovery”
Vaccines and Therapeutics for Anthrax
$1,066,759Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
UIC: In vitro In vivo Mtb Pharmacology
$1,066,689Scott G. Franzblau · Global Alliance For Tb Drug Development · U19 · FY2021 · AI
Red Cell Biology
$1,066,618David M. Bodine · National Human Genome Research Institute · ZIA · FY2022 · HG
ADDITIVE MANUFACTURING OF PDMS MICROFLUIDICS
$1,066,595Jeffrey Schultz · Phase, Inc. · R44 · FY2023 · TR
Center of Excellence for High Throughput Proteogenomic Characterization
$1,066,337Steven A. Carr · Broad Institute, Inc. · U24 · FY2023 · CA
Targeting Pediatric Cancer Vulnerabilities
$1,066,178Kimberly Stegmaier · Dana-Farber Cancer Inst · R35 · FY2023 · CA
RADIANT
$1,066,134Ashok Balasubramanyam · Baylor College Of Medicine · U54 · FY2024 · DK
UMGCC Paul Calabresi Clinical Oncology Training Program
$1,065,746Edward A Sausville · University Of Maryland Baltimore · K12 · FY2012 · CA
Integrating targeted and immunotherapy to treat genetically heterogeneous cancers
$1,065,613William A Weiss · University Of California, San Francisco · U01 · FY2017 · CA
Parent Project - Main Theme (MAIN)
$1,065,585Mark J Ratain · University Of Chicago · U01 · FY2011 · GM
Mixed Opioid Agonists / Cholecystokinin Antagonists for Treatment of Pain
$1,065,579Edward Roberts · Scripps Research Institute, The · U01 · FY2007 · NS
Tetracycline derivatives as SMN2 mRNA splicing modifiers for treatment of SMA.
$1,065,515Paul J Higgins · Paratek Pharmaceuticals · U01 · FY2010 · NS
Tetracycline derivatives as SMN2 mRNA splicing modifiers for treatment of SMA.
$1,065,515Paul Higgins · Paratek Pharmaceuticals · U01 · FY2010 · NS
Targeting Pediatric Cancer Vulnerabilities
$1,065,492Kimberly Stegmaier · Dana-Farber Cancer Inst · R35 · FY2025 · CA
A 3D IN VITRO DISEASE MODEL OF ATRIAL CONDUCTION
$1,065,481Steven Carl George · University Of California At Davis · UH3 · FY2021 · HL
Center for Genomics and Society
$1,065,387Gail E Henderson · Univ Of North Carolina Chapel Hill · P50 · FY2008 · HG
RNAi Screening in Hematopoietic Cells
$1,065,285Iain Fraser · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Use of systems pharmacology to prevent rod and cone photoreceptor degeneration
$1,065,041Krzysztof Palczewski · University Of California-Irvine · R24 · FY2018 · EY
AdaptiSPECT-C: A Next-Generation, Adaptive Brain-Imaging SPECT System for Drug Discovery and Clinical Imaging
$1,064,648Michael A King · Univ Of Massachusetts Med Sch Worcester · R01 · FY2016 · EB
NIDA Center of Excellence OF Computational Drug Abuse Research (CDAR)
$1,064,603Xiang-Qun Xie · University Of Pittsburgh At Pittsburgh · P30 · FY2015 · DA
COBRE Transitional Center in Neuroscience
$1,064,491George A Spirou · West Virginia University · P30 · FY2014 · GM
Identification of novel MDR antimicrobials from symbioses between terrestrial and marine invertebrates and rare microbial taxa
$1,064,370Timothy S Bugni · University Of Wisconsin-Madison · U19 · FY2019 · AI
Regulation of Osteoblast Differentiation by Delta FosB
$1,063,933Roland E Baron · Harvard Medical School · R01 · FY2009 · AR
Center for Targeted Therapeutics 2
$1,063,913Hippokratis Kiaris · University Of South Carolina At Columbia · P20 · FY2023 · GM
SRC ON PRIMARY AND METASTATIC TUMORS OF THE CNS
$1,063,812Duke University · P50 · FY2000 · NS